Covidien wins reversal of Becton Dickinson needle patents suit
July 30, 2010 by MassDevice staff
A federal appeals court tosses a trial judge's $58 million damage award for Becton, Dickinson & Co. in the lastest round of a patent battle with Covidien Plc. over safety syringes.
Covidien Plc. (NYSE:COV) won an appeal of a trial judge's decision to back Becton Dickinson and Company's (NYSE:BDX) patent infringement claim.
The U.S. Court of Appeals for the Federal Circuit in Washington on Thursday tossed the $58 million damage award against the Mansfield, Mass. based medical products conglomerate, formerly Tyco Healthcare, over safety syringes.
The 2-1 decision reversed the former ruling that found Covidien's Monoject Magellan syringes infringed on a BD patent.
The Franklin Lakes, N.J.-based BD is still considering its options, according to reports.
Covidien yesterday announced a $364 million profit on 2.6 billion in sales for the second quarter.
BD yesterday said that its profits dropped 10 percent during the third quarter.
- Login or register to post comments
-
Printer-friendly version
Permalink
Similar entries
- Covidien wins $5 million in patent suit against Applied Medical
- Applied Medical soldiers on in patent fight against Covidien
- Covidien settles endotrach tube suit with Kimberly-Clark
- Fed court decision in Boston Scientific patent case has wide-ranging implications
- Supremes rebuff Boston Scientific appeal
NEWS
Medtronic vet guides Cameron Health
Warren Watson, a 30-year Medtronic Inc. employee with family connections to founder Earl Bakken, is...
Quidel gains FDA clearance for pregnancy test
Quidel Corp. wins Food & Drug Administration 510(k) clearance for its chorionic gonadotropin-...
Ex-FDA commissioner joins board of Michigan cancer treatment firm
Ann Arbor, Mich.-based HistoSonics Inc. snags former Food & Drug Administration commissioner Dr....
FDA releases July 510(k) clearances
The Food & Drug Administration releases a list of the medical devices it granted 510(k) clearance...
Feds indict former Spectranetics execs
A federal grand jury indicts former Spectranetics CEO John Schulte, two other executives and a...
Top News Stories
SEARCH JOBS
RECENT BLOG POSTS
- Asian regulatory update: Hong Kong's hospitals to purchase new medical equipment
- Born to sell?
- Weekly Wireless Roundup: Monitor your baby with wireless pajamas
- Tips on "getting found" on LinkedIn
- Social media can be device makers' best friends
- MedGadget's MedTech Monday: Synthetic cornea offers performance on par with cadaver cornea after two years
- iConfess: Actions of a former brand skeptic
- What the heck is a medical device anyway?
- Weekly Wireless Roundup: GPS-enabled inhalers for rural sufferers of asthma
- MedGadget's MedTech Monday: Multicolor CT analysis of atherosclerotic plaque
Navigation
